Newsfeeds - Spark Newswire

1 minute read

GlaxoSmithKline Q3 EPS £0.46 Up From £0.37 YoY, Sales £7.83B Up From £6.63B YoY

Today, 1:59 PM

GlaxoSmithKline (NYSE:GSK) reported quarterly earnings of £0.46 per share. This is a 22.99 percent increase over earnings of £0.37 per share from the same period last year. The company reported £7.83

GSK

1 minute read

GSK Pulls Plug On Late-Stage Asset Under Development For Rheumatoid Arthritis

By Vandana Singh

Today, 1:59 PM

GSK plc (NYSE:GSK) has issued an update on the ContRAst phase 3 program for otilimab, an investigational monoclonal antibody for moderate…

GSK

1 minute read

FDA
News

U.S. FDA Advisers Say Benefits Do Outweigh Risks For GSK’s Daprodustat For Treatment Of Anemia Due To Chronic Kidney Disease In Adults On Dialysis

By Michael Horton

Today, 1:59 PM

-Reuters-Reuters

GSK

1 minute read

GSK Transfers Cell Therapy Program Rights To Adaptimmune, Terminates Second Cell Therapy Pact In A Day

By Vandana Singh

Today, 1:59 PM

GSK plc (NYSE:GSK) will transfer its NY-ESO cell therapy program and the right to the PRAME cell therapy program to Adaptimmune Therapeutics…

ADAP

4 minute read

ViiV Healthcare Presents Positive Proof-Of-Concept Findings For N6LS, An Investigational, Broadly Neutralising Antibody Offering A Potential New Approach For The Treatment Of HIV

By Benzinga Newsdesk

Today, 1:59 PM

Data from the BANNER study show antiviral efficacy, safety, and tolerability of N6LS, supporting its continued study in phase IIb ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and

GSK

1 minute read

GSK Walks Away From T-Cell Therapy Pact With Lyell Citing Strategic Actions

By Vandana Singh

Today, 1:59 PM

GSK plc (NYSE:GSK) has decided to terminate the License and Collaboration Agreement with Lyell Immunopharma Inc (NASDAQ:LYEL). The termination is effective on December…

GSK

1 minute read

News

Lyell Immunopharma Says Termination of GSK Agreement Has Minimal Impact To Co.’s Operations, Says Termination Is Effective On Dec. 24, 2022

By Michael Horton

Today, 1:59 PM

-Reuters

GSK

1 minute read

Children’s Hospitals Strained After Climbing Cases In Respiratory Illnesses In Kids

By Vandana Singh

Today, 1:59 PM

Physicians are reporting a sharp increase in cases of the respiratory syncytial virus (RSV), creating capacity issues in several children's hospitals in the U.S. before the typically busier winter months.

AZN

1 minute read

This Addiction Drug Shows Some Potential Against Long COVID Symptoms

By Vandana Singh

Today, 1:59 PM

Researchers are working on cures for long COVID. With some success, naltrexone has been used to treat pain, fatigue, and brain fog months after a coronavirus infection.

GSK

1 minute read

Analyst Thinks This Company’s Bone Marrow Cancer Treatment Can ‘Transform Paradigm’

By Vandana Singh

Today, 1:59 PM

SVB Leerink initiated coverage on CTI Biopharma Corp (NASDAQ:CTIC) with an Outperform rating and a $13 price target. CTIC is a commercial-stage…

CTIC